# OnCo record nct06526793 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06526793/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06526793", "NCT06526793" ;
  schema:name "Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL"@en ;
  schema:alternateName "SOUNDTRACK-B"@en ;
  schema:description "A phase 2 trial of AZD0486 in hodgkin lymphoma and non-hodgkin lymphoma, run by AstraZeneca, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06526793/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06526793> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-11-27" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/azd0486/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .
